Immune cells in overdrive: Study finds unbalanced response worsens lung infections

CD4+ T cells have been highlighted in the scientific literature for the important role they play in the immune response to lung infections.

Study: Patients Better Be Very Literate to Understand These Handouts

Patient education materials (PEMs) in rheumatology and general medicine demanded greater literacy than is typically recommended, researchers found. Handouts from the American College of Rheumatology

December 3, 2024

Biogen is pursuing more dealmaking this year, with plans to spend up to $8B

Biogen appears to be subtly signaling it has a larger appetite for M&A than previously stated. In an exclusive interview with Endpoints News, Biogen head

June 28, 2024

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 – Biotech Investments

Issuer: CureVac / Key word(s): Quarter Results 07.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Report

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.